Drug sodium intake: Warning in cardiovascular diseases treatment

Introduction: Hypertension is a condition which represents one of the main risk factors for the development of cardiovascular diseases. High sodium intake contributes to occurrence of hypertension, increasing the volume of extracellular fluid. Therefore, World Health Organization (WHO) and other ass...

Full description

Bibliographic Details
Main Authors: Čanji Jelena M., Todorović Nemanja B., Čović Bojana Z., Pavlović Nebojša M., Jovičić-Bata Jelena N., Goločorbin-Kon Svetlana S., Lalić-Popović Mladena N.
Format: Article
Language:English
Published: Srpsko lekarsko drustvo 2020-01-01
Series:Hospital Pharmacology
Subjects:
Online Access:https://scindeks-clanci.ceon.rs/data/pdf/2334-9492/2020/2334-94922002913Q.pdf
_version_ 1819159519796658176
author Čanji Jelena M.
Todorović Nemanja B.
Čović Bojana Z.
Pavlović Nebojša M.
Jovičić-Bata Jelena N.
Goločorbin-Kon Svetlana S.
Lalić-Popović Mladena N.
author_facet Čanji Jelena M.
Todorović Nemanja B.
Čović Bojana Z.
Pavlović Nebojša M.
Jovičić-Bata Jelena N.
Goločorbin-Kon Svetlana S.
Lalić-Popović Mladena N.
author_sort Čanji Jelena M.
collection DOAJ
description Introduction: Hypertension is a condition which represents one of the main risk factors for the development of cardiovascular diseases. High sodium intake contributes to occurrence of hypertension, increasing the volume of extracellular fluid. Therefore, World Health Organization (WHO) and other associations involved with hypertension research advise to decrease intake of sodium. Effervescent dosage forms usually contain high levels of sodium which could lead to above mentioned health issues. Aim: The aim of this study was to evaluate the levels of sodium in the effervescent dosage forms available in the Serbian drug market. Methods: Data about sodium levels, and excipients was obtained from Summary of Product Characteristics from website of Medicines and Medical Devices Agency of Serbia (ALIMS). Maximum daily doses recommended by the manufacturer and approved by ALIMS were observed. Exposure to sodium through consumption of maximum daily doses was calculated as percentages of the adequate daily intake given by Food and Nutrition Board (Institute of Medicine, National Academies, Washington D.C., USA), and also as percentage of recommended daily intake of sodium given by WHO. Results: There are five formulations with exposure to sodium through consumption of maximum daily doses higher than 100% of the adequate daily intake (2 g), all of which are effervescent tablet formulations. The highest exposure to sodium was found in effervescent tablets containing acetylsalycic acid (500 mg) as active pharmaceutical ingredient: 250.62 % for people aged 51 to 70 years; 271.50 % for people aged 70 and older. Conclusion: In effervescent dosage forms available on Serbian market, level of sodium can be very high, even up to 271.50% of adequate daily intake when maximum daily doses are consumed. Major cause for concern is for vascular patients who use effervescents for chronic therapy. This data should be considered during prescribing and dispensing this category of medicines as well as during analyzing pharmacovigilance.
first_indexed 2024-12-22T16:41:51Z
format Article
id doaj.art-b376a91b6fdc4635bee1f1cd01013920
institution Directory Open Access Journal
issn 2334-9492
2334-9492
language English
last_indexed 2024-12-22T16:41:51Z
publishDate 2020-01-01
publisher Srpsko lekarsko drustvo
record_format Article
series Hospital Pharmacology
spelling doaj.art-b376a91b6fdc4635bee1f1cd010139202022-12-21T18:19:51ZengSrpsko lekarsko drustvoHospital Pharmacology2334-94922334-94922020-01-01729139222334-94922002913QDrug sodium intake: Warning in cardiovascular diseases treatmentČanji Jelena M.0Todorović Nemanja B.1Čović Bojana Z.2Pavlović Nebojša M.3Jovičić-Bata Jelena N.4Goločorbin-Kon Svetlana S.5https://orcid.org/0000-0002-2850-6375Lalić-Popović Mladena N.6https://orcid.org/0000-0001-8354-3868University of Novi Sad, Faculty of Medicine, Department of Pharmacy, SerbiaUniversity of Novi Sad, Faculty of Medicine, Department of Pharmacy, SerbiaUniversity of Novi Sad, Faculty of Medicine, Department of Pharmacy, SerbiaUniversity of Novi Sad, Faculty of Medicine, Department of Pharmacy, SerbiaUniversity of Novi Sad, Faculty of Medicine, Department of Pharmacy, SerbiaUniversity of Novi Sad, Faculty of Medicine, Department of Pharmacy, SerbiaUniversity of Novi Sad, Faculty of Medicine, Department of Pharmacy, SerbiaIntroduction: Hypertension is a condition which represents one of the main risk factors for the development of cardiovascular diseases. High sodium intake contributes to occurrence of hypertension, increasing the volume of extracellular fluid. Therefore, World Health Organization (WHO) and other associations involved with hypertension research advise to decrease intake of sodium. Effervescent dosage forms usually contain high levels of sodium which could lead to above mentioned health issues. Aim: The aim of this study was to evaluate the levels of sodium in the effervescent dosage forms available in the Serbian drug market. Methods: Data about sodium levels, and excipients was obtained from Summary of Product Characteristics from website of Medicines and Medical Devices Agency of Serbia (ALIMS). Maximum daily doses recommended by the manufacturer and approved by ALIMS were observed. Exposure to sodium through consumption of maximum daily doses was calculated as percentages of the adequate daily intake given by Food and Nutrition Board (Institute of Medicine, National Academies, Washington D.C., USA), and also as percentage of recommended daily intake of sodium given by WHO. Results: There are five formulations with exposure to sodium through consumption of maximum daily doses higher than 100% of the adequate daily intake (2 g), all of which are effervescent tablet formulations. The highest exposure to sodium was found in effervescent tablets containing acetylsalycic acid (500 mg) as active pharmaceutical ingredient: 250.62 % for people aged 51 to 70 years; 271.50 % for people aged 70 and older. Conclusion: In effervescent dosage forms available on Serbian market, level of sodium can be very high, even up to 271.50% of adequate daily intake when maximum daily doses are consumed. Major cause for concern is for vascular patients who use effervescents for chronic therapy. This data should be considered during prescribing and dispensing this category of medicines as well as during analyzing pharmacovigilance.https://scindeks-clanci.ceon.rs/data/pdf/2334-9492/2020/2334-94922002913Q.pdfsodium contenthypertensionvascular therapy
spellingShingle Čanji Jelena M.
Todorović Nemanja B.
Čović Bojana Z.
Pavlović Nebojša M.
Jovičić-Bata Jelena N.
Goločorbin-Kon Svetlana S.
Lalić-Popović Mladena N.
Drug sodium intake: Warning in cardiovascular diseases treatment
Hospital Pharmacology
sodium content
hypertension
vascular therapy
title Drug sodium intake: Warning in cardiovascular diseases treatment
title_full Drug sodium intake: Warning in cardiovascular diseases treatment
title_fullStr Drug sodium intake: Warning in cardiovascular diseases treatment
title_full_unstemmed Drug sodium intake: Warning in cardiovascular diseases treatment
title_short Drug sodium intake: Warning in cardiovascular diseases treatment
title_sort drug sodium intake warning in cardiovascular diseases treatment
topic sodium content
hypertension
vascular therapy
url https://scindeks-clanci.ceon.rs/data/pdf/2334-9492/2020/2334-94922002913Q.pdf
work_keys_str_mv AT canjijelenam drugsodiumintakewarningincardiovasculardiseasestreatment
AT todorovicnemanjab drugsodiumintakewarningincardiovasculardiseasestreatment
AT covicbojanaz drugsodiumintakewarningincardiovasculardiseasestreatment
AT pavlovicnebojsam drugsodiumintakewarningincardiovasculardiseasestreatment
AT jovicicbatajelenan drugsodiumintakewarningincardiovasculardiseasestreatment
AT golocorbinkonsvetlanas drugsodiumintakewarningincardiovasculardiseasestreatment
AT lalicpopovicmladenan drugsodiumintakewarningincardiovasculardiseasestreatment